Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.705 USD | -3.24% | -8.20% | -25.59% |
Financials (USD)
Sales 2024 * | 2M | Sales 2025 * | 3.33M | Capitalization | 53.04M |
---|---|---|---|---|---|
Net income 2024 * | -94M | Net income 2025 * | -106M | EV / Sales 2024 * | 26.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 15.9 x |
P/E ratio 2024 * |
-0.58
x | P/E ratio 2025 * |
-0.6
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.16% |
Latest transcript on Kezar Life Sciences, Inc.
1 day | -5.62% | ||
1 week | -5.13% | ||
Current month | -11.63% | ||
1 month | -11.79% | ||
3 months | -19.06% | ||
6 months | -20.11% | ||
Current year | -23.09% |
Managers | Title | Age | Since |
---|---|---|---|
Christopher Kirk
FOU | Founder | 52 | 15-02-18 |
John Fowler
FOU | Founder | 52 | 15-02-18 |
Marc Belsky
DFI | Director of Finance/CFO | 68 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 16-10-31 |
Graham Cooper
CHM | Chairman | 54 | 17-09-30 |
Michael Kauffman
BRD | Director/Board Member | 60 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.705 | -3.24% | 496 979 |
24-05-23 | 0.7286 | -5.62% | 524,374 |
24-05-22 | 0.772 | -0.50% | 208,330 |
24-05-21 | 0.7759 | +0.78% | 571,591 |
24-05-20 | 0.7699 | +0.55% | 563,761 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.09% | 53.04M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.09% | 21.58B | |
-10.56% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- KZR Stock